European Society for Medical Oncology (ESMO): Poster presentation: Mortality after Rasburicase versus Allopurinol Anti-Hyperuricaemia Monotherapy in Patients with Liquid Tumours. authors: Cairo MS, Gallagher JR, Drea E, Barnes Y, Clark C, Carroll S (October 2023, Madrid, Spain)

​​ American Society of Hematology (ASH) 64th Annual Meeting, poster presentation: Fatalities from Tumor Lysis Syndrome (TLS) After Anti-Hyperuricemic Monotherapy – Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol; authors: Cairo MS, Gallagher JR, Barnes Y, Drea E, Carroll S. (December 2022, New Orleans, LA)
 Society of Hematologic Oncology (SOHO) 10th Annual Meeting: poster presentation: Comparison of Nationally Representative Samples of Rasburicase vs. Allopurinol Post-Hyperuricemia Monotherapy in Patients with Hematological Malignancies: Significant Reduction in Tumor Lysis Syndrome Mortality with Rasburicase; authors: Cairo MS, Gallagher JR, Barnes Y, Drea E, Carroll S. (September 2022, Houston, TX) Reprised Autumn 2022 at Florida Society of Clinical Oncology (FLASCO) SOHO Poster

​ World Congress on Dermatology Research, J. Gallagher speaking (virtual), Tokyo, Japan, April 2022 

​ 6th Annual Microbiome Movement Drug Development Europe Conference, J. Gallagher speaking, London (via webcast), January 25, 2022
​ International Conference on Clinical & Experimental Dermatology & Cosmetic Surgery: Jack Ray Gallagher speaker: Rare genetic conditions in dermatology - Future practice implications: An underdiagnosed example. (October 2020 [rescheduled virtual], Vancouver, Canada)
― 4th Annual PCDI Global Obstetrics and Gynaecology Congress: Gallagher JR, presentation: Growing Importance of Real-World-Occurrence (RWO) Studies, a Recent Example – Adverse Events in PARP Inhibitor (Niraparib) Maintenance Treatment for Recurrent Ovarian Cancer (June 2019, Prague, Czech Republic)
 American Diabetes Association 79th Scientific Sessions: Mehta SN, Kruger DF, Bode BW, Layne JE, Dumais B, Gallagher JR, Ly TT: Effect of the Omnipod Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CDIII (June 2019, San Francisco)
 European Society for Medical Oncology (ESMO): Gallagher JR, Heap KH, Carroll S: Poster presentation: Real world occurrence of top three clinical-trial reported adverse events of PARP inhibitor niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer, a US-based retrospective observational study of a 200 mg/day starting-dose cohort (October 2018, Munich, Germany) 

 American Academy of Neurology, poster on treatment for rare infantile spasms, 69th annual meeting (April 2017, Boston); also published as abstract in Neurology supplement (April 2017) Abstract; Poster

International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 19th Annual European Congress,2 poster presentations on findings from an economic burden of illness study of a rare infection in Europe and Canada (November 2016, Vienna, Austria)  Poster1Poster2

ISPOR, 18th Annual European Congress, retrospective observational study to capture economic burden evidence in a rare disease (November 2015, Milan, Italy) AbstractPoster

— EphMRA (European Pharmaceutical Market Research Association), “Precedent and consequence research to undergird orphan reimbursement strategy – A multi-layered, non-traditional approach,” (June 2015, Amsterdam, Netherlands) Presentation

Japanese Respiratory Society, Co-author, poster presentation on Clarity Pharma study comparing treatment patterns for a rare lung disease in EU5, Japan and US (April 2015, Tokyo, Japan) Abstract

 European Respiratory Society, Co-author of presentation on Clarity study of prevalence and incidence of a rare lung disease in Europe: Text and Poster1; co-author, comparisons of treatment patterns for the disease in EU5, Japan and US (September 2014, Munich, Germany) Text; Poster2

— KIT 2014 (Congress for Infectious Diseases and Tropical Medicine), co-author, rare lung infection prevalence in Germany (June 2014, Cologne) Abstract

— EphMRA Annual conference, fieldwork challenges debate, (June 2013, London) Presentation
American Thoracic Society (ATS) International Conference, study of rare lung infection, co-written with 2 NIH epidemiologists (May 2013, Philadelphia) Abstract
PMRG Institute (Pharmaceutical Marketing Research Group), cancer study and sample validity (October 2012, Philadelphia) Abstract; Poster
PBIRG (Pharmaceutical Business Intelligence and Research Group), presentation on sample validity (May 2012, Chicago) Poster
Market Research Society (MRS) Healthcare Research Conference, surveys (February 2012, London) Presentation
Society of Urologic Oncology (SUO) Annual Meeting in conjunction with World Urologic Oncology Federation, cancer study (December 2011, Rockville, Md.) Poster
American Urological Association (AUA) Annual Meeting, cancer study (May 2011, Washington, D.C. – one of 696 selected from 6,638 submissions) Abstract; Presentation
ISPOR 16th Annual International Meeting, posters based on Clarity cancer study (May 2011, Baltimore, Md.) Presentation1; Presentation2
ASCO, Duration of Therapy of Colony Stimulating Factors (May 2002) Paper

  • Our research has withstood the scrutiny of peer-review journals and medical conferences, which can help you in showing evidence of value and efficacy to payors and regulators. 

  • Clarity's co-investigators have contributed to medical research and have served at prestigious agencies, medical schools, and universities in the US and overseas.

© 2014-2023 Clarity Pharma Research® LLC  |  All Rights Reserved Privacy Policy
To learn more about our services, contact information@claritypharma.com.



Disadvantages of Commonly Used Alternatives to a Patient Records Approach (PDF)
Sargramostim (GM-CSF) as Immunotherapy (PDF)
CSF Efficacy and Other Key Attributes (PDF)
National Representative Actinic Keratoses Study: Key Findings Among Dermatologists (PDF)
National Representative Actinic Keratoses Study: Key Findings Among PCPs (PDF)
National Descriptive Blood and Marrow Study: Transplants Performed in US (PDF)
HIV / AIDS Anemia (PDF)
Hepatitis C Treatment Associated Anemia (PDF)
Metastatic Melanoma Treatment (PDF)
Basal Cell Carcinoma Treatment (PDF)
Metastatic Renal Cell Carcinoma Treatment (PDF)
Undiagnosed Chronic Kidney Disease Among Rheumatoid Arthritis Patients (PDF)
How Patient-Records Methodology Can Help Overcome Shortcomings of ATU and Syndicated Data (PDF)
Why Peer-Reviewed Publications Matter to Your Business (PDF)

Articles & Other Writings 
― Clinical Lymphoma, Myeloma & Leukemia, Cairo M, Gallagher JR, Barnes Y, Drea E, Carroll S. Fatalities from Tumor Lysis Syndrome (TLS) After Anti-Hyperuricemic Monotherapy – Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol, Clin Lymphoma
​Myeloma Leuk, Volume 22, Supplement 2, 2022, 
Pages S302-S303, ISSN 2152-2650 https://doi.org/10.1016/S2152-2650(22)01393-3.

― Orphanet Journal of Rare Diseases,Gallagher J, Martini J, Carroll S, Small A, Teng J. Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians. May 2022
Orphanet J. Rare Dis 17(1) DOI: 10.1186/s13023-022-02336-3

― Respiratory Medicine, Schildkraut J, Gallagher J.R., Morimoto, K. et al. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. J. Respir. Med. 2020 Nov; Vol 176 DOI: https://doi.org/10.1016/j.rmed.2020.106164.
Future Oncology, Gallagher JR, Heap KJ, Carroll S, Travers K, Harrow B, Westin SN. Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study. Future Oncol. 2019 Dec;15(36):4197-4206. doi: 10.2217/fon-2019-0471. Epub 2019 Nov 11.
― Therapeutic Advances in Respiratory Disease, Chopra, I., Qin, Y., Kranyak, J., Gallagher, J.R., Heap, K., Carroll, S., & Wan, G. J. (2019). Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Ther Adv Respir Dis. 2019 Jan-Dec; 13: 1753466619888127. doi: 10.1177/1753466619888127.
― Current Trends in Clinical & Medical Sciences, editorial by Dr. Gallagher titled: If medical science could provide a solution to one healthcare issue which would you choose? (September 2019)
― Dermatology and Dermatologic Diseases, Gallagher JR, Lapidus D, Heap K, Carroll S. Prevalence of Diagnosed/Highly Symptomatic Pachyonychia Congenita (PC) Patients Managed Annually by US Dermatologists-National Real World Occurrence (RWO) Physician Study, J Dermatol Dis, Vol. 6, Issue 1, July 2019
 Diabetes, Mehta, Sanjeev; Kruger, Davida; Bode, Bruce; Layne, Jennifer; Dumais, Bonnie; Gallagher, Jack; Ly, Trang. (2019). 1061-P: Effect of the Omnipod ® Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CDIII. Diabetes. 68. 1061-P. 10.2337/db19-1061-P
― American Journal of Perinatology Reports, Gallagher J, Gudeman J, Heap K, Vink J, Carroll S. Understanding If, How, and Why Women with Prior Spontaneous Preterm Births are Treated with Progestogens: A National Survey of Obstetrician Practice Patterns, Am J Perinatol Rep 2018;8: e315–e324

― Journal of Ocular Pharmacology and Therapeutics, Nelson WW, Lima AF, Kranyak J, Opong-Owusu B, Ciepielewska G, Gallagher JR, Heap K, Carroll S. Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States. J Ocul Pharmacol Ther. 2019 Apr;35(3):182-188. doi: 10.1089/jop.2018.0090. Epub 2019 Jan 24.
Rheumatology and Therapy, co-authors, article on utilization patterns and medical resource use of a product among patients with rheumatologic diseases (December 2017; online October 2017) Article
— European Respiratory Journal, co-author, research letter on poor adherence to treatment guidelines for a rare pulmonary disease (December 2016) Abstract
— Urology Practice, co-author, retrospective chart review analysis of genomic assay used in men newly diagnosed with prostate cancer (November 2015; online July 2015) Abstract
—​ European Respiratory Journal, Clarity Pharma study, prevalence of a rare lung infection in Europe, co-written with international team of medical experts (September 2014) Abstract
European Respiratory Journal, Clarity Pharma study, treatment patterns for a rare lung infection in Europe, US and Japan, co-written with international team of medical experts (September 2014) Abstract
Annals of the American Thoracic Society, US study of rare lung infection, co-written with 2 NIH epidemiologists and a professor of medicine on national ATS guidelines committee (January 2014) Abstract
World Journal of Urology, 5-nation European cancer study, co-written with 2 European urology oncologists on disease treatment guidelines panel (April 2014)
The Journal of Urology, cancer study, co-writtten with nationally known medical researchers (May 2012 – offered for Category 1 CME credit)
The Journal of Urology, cancer practice patterns,
AUA Annual Meeting Program Abstracts special issue,

(April 2011) Citation
Journal of Dermatological Treatment, article on actinic keratoses treatments and outcomes (2006)
Journal of Health Care Marketing, article on a study of patient selection of orthopedists, podiatrists and PCPs for foot treatments, by Clarity chief scientist, reprinted in the book Health Care Marketing: A Foundation for Managed Quality (3rd ed., Philip D. Cooper, editor) 
Abstract; Chapter
Journal of Health Care Marketing, Violating assumptions of statistical procedures: JHCM reporting guidelines (September 1990)
Journal of Health Care Marketing, Invalid Patient Surveys: Not a Bargain at Any Price (March 1989)
Nursing Management, article on developing an optimal nurse staffing system (March 1987)
American Journal of Mental Deficiency, article on Dr. Gallagher's experimental study of short-term memory in the cognitively impaired.
— Changing Behavior: How and Why (book by Dr. Gallagher, Silver Burdett Professional Publications)

A Sampling of Our Published Research & Presentations

(Including nonproprietary findings for study physician participants and the public, with clients’ permission) 

(Click on links in gray to view or download materials)

Clarity and co-investigators have presented at a number of conferences.We presented this poster at the 2012 PMRG Institute (view PDF).